-
Mashup Score: 2NIHR Impact Prizes - 4 month(s) ago
Every day NIHR research saves lives and improves the quality of life of the public. The research we support drives improvements to our health and care services, resulting in better wellbeing, better productivity, and significant contributions to the wider economy. Our brand new NIHR Impact Prizes will celebrate researchers and teams who have maximised the impact of their research and whose research has transformed people’s lives or promoted economic growth. The Impact Prizes are open to those who have
Source: www.nihr.ac.ukCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 4Ministry of Health Press Conference - February 11 2025 - 4 month(s) ago
The Prostate Cancer Pathway. The Hon. Kim Wilson, Minister of Health, Scott Pearman, BHB CEO and Dr. Jonathan Makanjuola, BHB Consultant Urologist.
Source: www.youtube.comCategories: General Medicine News, Hem/OncsTweet-
RT @jonmakUrology: Ministry of Health Press Conference - February 11 2025 https://t.co/wMr2iCUzY6 via @YouTube
-
-
Mashup Score: 72Tour de 4: Sir Chris Hoy's - Zwift Rides, organized by Zwift Rides - 5 month(s) ago
The Tour de 4 is an initiative launched by Sir Chris Hoy to change the perception… Zwift Rides needs your support for Tour de 4: Sir Chris Hoy’s – Zwift Rides
Source: www.gofundme.comCategories: General Medicine News, Hem/OncsTweet-
Just completed the inspirational Chris Hoy’s inaugural Tour de 4 Zwift fundraiser for prostate cancer. Donate now! https://t.co/UJbNRAAa2p https://t.co/dZVSxdndHk
-
-
Mashup Score: 63The Man Van: A pilot study of using mobile targeted case‐finding to address health inequalities in prostate cancer - 7 month(s) ago
Men from deprived groups are at increased risk of delayed prostate cancer diagnosis. To ease access to PSA blood testing and follow-up for ethnic minority men and men in deprived communities, the Roy…
Source: onlinelibrary.wiley.comCategories: General Medicine News, Hem/OncsTweet-
Our paper on the Pilot Phase of the Man Van project now out. High rates of prostate cancer detection in area of high deprivation. Plus other pathology - diabetes and hypertension especially. @ICR_London @RMPartnersNHS @royalmarsdenNHS @MMoghul https://t.co/plF0Y7nSza
-
-
Mashup Score: 1The Man Van: A pilot study of using mobile targeted case-finding to address health inequalities in prostate cancer - PubMed - 7 month(s) ago
Early diagnosis remains a major limitation of cancer outcomes with ethnicity and deprivation being determinants of inequalities that impact outcomes. Prostate cancer suffers from lower incidence rates and higher mortality rates in the most deprived versus the least deprived groups. We developed the …
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet-
Full details https://t.co/mc2lTrEjvS https://t.co/AYk4HQCb5V
-
-
Mashup Score: 61The Man Van: A pilot study of using mobile targeted case‐finding to address health inequalities in prostate cancer - 10 month(s) ago
Men from deprived groups are at increased risk of delayed prostate cancer diagnosis. To ease access to PSA blood testing and follow-up for ethnic minority men and men in deprived communities, the Roy…
Source: onlinelibrary.wiley.comCategories: General Medicine News, Hem/OncsTweet-
Our paper on the Pilot Phase of the Man Van project now out. High rates of prostate cancer detection in area of high deprivation. Plus other pathology - diabetes and hypertension especially. @ICR_London @RMPartnersNHS @royalmarsdenNHS @MMoghul https://t.co/plF0Y7nSza
-
-
Mashup Score: 79pendingpublications - 10 month(s) ago
Pending Publication
Source: apps.crossref.orgCategories: General Medicine News, Hem/OncsTweet-
Out today, the full report on BladderPath - MRI directed staging for newly diagnosed bladder cancer vs TURBT. Early use of MRI halves time to treatment for MIBC. Time to rethink the staging pathway. @CRCTU @ICR_London https://t.co/hWXcURZcrJ
-
-
Mashup Score: 24Trials & Tribulations Episode 8: Early Phase Clinical Trials featuring Professor Udai Banerji - 11 month(s) ago
Episode · Trials and Tribulations | Oncology Trials Podcast · In Episode 8, featuring Professor Udai Banerji, we discuss the set up of early phase clinical trials.
Source: open.spotify.comCategories: General Medicine News, Hem/OncsTweet-
How should we do Phase 1 trials in the era of targeted therapies, immune therapies and bispecific drug conjugates. Is the traditional 3+3 model irrelevant? How do we do pharmacokinetics? Listen to Phase 1 trial maestro @udai_banerji in our latest episode. https://t.co/Dj9IFWR0qM
-
-
Mashup Score: 33Trials & Tribulations Episode 7: International Clinical Trial Collaborations featuring Professor Neha Vapiwala - 11 month(s) ago
Listen to this episode from Trials and Tribulations | Oncology Trials Podcast on Spotify. In Episode 7, featuring Professor Neha Vapiwala, we discuss the strengths and challenges of clinical trial setup in the US, the intricacies of international collaborations, and provide an overview of next-generation imaging with PSMA PET in the STAMPEDE2 and INDICATE clinical trials.
Source: open.spotify.comCategories: General Medicine News, Hem/OncsTweet-
International collaboration in trials should be a no brainer - faster recruitment, broader representation of health care systems and expertise, etc. Why then is it relatively rare? Latest episode of @TrialsTribsPod discusses this with @NehaVapiwala https://t.co/CokOyip2M2
-
-
Mashup Score: 31Meta-Analysis Evaluates Cardiovascular Risks of AR Inhibitors in Prostate Cancer - Omar El-Taji & Ashwin Sachdeva - 11 month(s) ago
Alicia Morgans interviews Omar El-Taji and Ashwin Sachdeva about their JAMA Oncology publication on cardiovascular risks associated with androgen receptor signaling inhibitors (ARSIs) in prostate cancer treatment. Their meta-analysis reveals that ARSIs significantly increase the risk of cardiovascular events across all stages of prostate cancer, with abiraterone and enzalutamide showing the…
Source: www.urotoday.comCategories: General Medicine News, Hem/OncsTweet-
Great discussion of long term CV risks from AR targeted therapies from STAMPEDE team members @AshwinUrol and Omar El-Taj. We need to be very mindful of the potential harms and how we might mitigate them with these powerful drugs. https://t.co/Rwok2vWbmv
-
RT @AshwinUrol: Great to see the #STAMPEDE trial shortlisted for the @NIHRresearch Impact Prize 2025! 🏆 https://t.co/1pRtLRUvB7 @MRCCTU @…